Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women.
The DOI matches its Crossref record; 108 of the 115 references it cites were found in a registry or an index.
Abstract
We test the interlinked hypotheses that in healthy older adults: 1). i.v. injection of GH-releasing peptide-2 (GHRP-2) and GHRH synergizes more in aging women than men; 2). sc infusion of both GHRP-2 (1 microg/kg.h = 1) and GHRH (1, 3, or 10) for 24 h augments GH secretion more than either agonist alone; and 3). continuous sc delivery of GHRP-2 (1) for 30 d stimulates daily GH secretion and IGF-I, IGF-binding protein-3 (IGFBP-3), and IGFBP-5. Acute two-peptide synergy was 3-fold greater in young (n = 16) than older volunteers (n = 17; P < 0.025) and was 2.3-fold higher in elderly women than men (P < 0.025). The 24-h infusion of GHRP-2 (1) combined with GHRH (3 or 10) in men and with GHRH (10) in women drove GH secretion more than GHRH alone (P <or= 0.024). In the entire cohort (n = 11), GHRP-2/GHRH (1/10) stimulated GH secretion more than either GHRP-2 (1; P = 0.021) or GHRH (10; P = 0.012). The 30-d delivery of GHRP-2 (1; n = 17 subjects): 1). stimulated pulsatile, rhythmic, and entropic GH secretion by more than 3-fold on d 1 and more than 1.8-fold on d 14 and 30 (each P < 0.001 vs. saline); 2). elevated IGF-I to a stable plateau on d 1, 14, and 30 (P < 0.025 vs. baseline); and 3). increased IGFBP-3 (P < 0.01) and IGFBP-5 (P < 0.025) on d 14 and/or 30. Safety screening tests remained normal. In summary, in healthy elderly women and men: 1). acute synergy of GHRP-2 and GHRH is greater in the female; 2). 24-h combined GHRP-2 and GHRH drive is more effective than either agonist alone; and 3). 30-d stimulation with GHRP-2 sustains a physiologically activated somatotropic axis. We conclude that age, gender, stimulus duration, and secretagogue combination determine acute, intermediate, and extended responses of the somatotropic axis in the older adult.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“continuous sc GHRP-2 infusion for 1 month stimulates GH secretion by 2-fold more in older estrogen-replaced women than comparably aged men (63).”
From Determinants of dual secretagogue drive of burst-like growth hormone secretion in premenopausal women studied under a selective estradiol clamp (2005) · cites this paper as [63]
Citations
Cites
Statistical principles in experimental design.
Winer, B. J. (1962) · McGraw-Hill Book Company · doi:10.1037/11774-000 · Cited by 26,755
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479
Statistical Principles in Experimental Design
Green, P. E., Winer, B. J., Brown, D. R., & Michels, K. M. (1992) · Journal of Marketing Research · doi:10.2307/3172747 · Cited by 4,333
A Receptor in Pituitary and Hypothalamus That Functions in Growth Hormone Release
Howard, A. D., Feighner, S. D., Cully, D. F., Arena, J. P., Liberator, P. A., Rosenblum, C. I., Hamelin, M., Hreniuk, D. L., Palyha, O. C., Anderson, J., et al. (1996) · Science · doi:10.1126/science.273.5277.974 · Cited by 2,073
Giustina, A., & Veldhuis, J. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0353 · Cited by 1,253
Self-citationRajaram, S., Baylink, D. J., & Mohan, S. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0321 · Cited by 1,097
Self-citationHO, K. Y., EVANS, W. S., BLIZZARD, R. M., VELDHUIS, J. D., MERRIAM, G. R., SAMOJLIK, E., FURLANETTO, R., ROGOL, A. D., KAISER, D. L., & THORNER, M. O. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-1-51 · Cited by 921
Self-citationBroglio, F. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.10.5083 · Cited by 720
Baxter, R. C. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.6.e967 · Cited by 672
BOWERS, C. Y., MOMANY, F. A., REYNOLDS, G. A., & HONG, A. (1984) · Endocrinology · doi:10.1210/endo-114-5-1537 · Cited by 654
Self-citation
Research works printed but not linked: 4
- Bowers, 1998, Synergistic release of growth hormone by GHRP and GHRH: scope and implication, In: Bercu BB, Walker RF, eds. Growth hormone secretagogues in clinical practice. New York: Marcel Dekker;, 1
- Van den Berghe, 1997, The somatotropic axis in critical illness: effects of continuous GHRH and GHRP-2 infusion., J Clin Endocrinol Metab, 82, 590
- Bowers, 2002, New insight into the control of growth hormone secretion, In: Kleinberg DL, Clemmons DR, eds. Central and peripheral mechanisms in pituitary disease. Bristal: BioScientifica;, 163
- Maccario, 2002, Impact of two or three daily subcutaneous injections of hexarelin, a synthetic GH secretagogue (GHS), on 24-hour GH, prolactin, ACTH and cortisol secretion in the human., Eur J Endocrinol, 146, 311
Cited by
Somatotropic and Gonadotropic Axes Linkages in Infancy, Childhood, and the Puberty-Adult Transition
Veldhuis, J. D., Roemmich, J. N., Richmond, E. J., & Bowers, C. Y. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0006 · Cited by 236
“In addition, little is known about the mechanisms that govern ghrelin’s acylation and deacylation (339, 340); how the peptide is secreted, transported in blood, and accumulated by target tissues (363); the precise roles of hypothalamic and pituitary ghrelin (14, 298, 300); and the bases for ghrelin’s CNS-dependent pot…”
BackgroundSelf-citationMotivations and Methods for Analyzing Pulsatile Hormone Secretion
Veldhuis, J. D., Keenan, D. M., & Pincus, S. M. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0005 · Cited by 223
Self-citationChanges in pituitary function with ageing and implications for patient care
Veldhuis, J. D. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.38 · Cited by 117
Self-citationVeldhuis, J. D. (2008) · Ageing Research Reviews · doi:10.1016/j.arr.2007.12.005 · Cited by 111
“During the second and fourth week of the intervention, GHRP-2 infusion stimulated 24-h GH secretion by 1.45-fold and elevated IGF-I concentrations by 1.65-fold (Bowers et al., 2004) (Fig.”
InfluentialSelf-citationIntegrating GHS into the Ghrelin System
Veldhuis, J. D., & Bowers, C. Y. (2010) · International Journal of Peptides · doi:10.1155/2010/879503 · Cited by 67
“Since hypothalamic GHRH release is prerequisite to maximal GH stimulation, GHSs have clinical therapeutic potential in treating: (i) idiopathic short stature in patients with preserved CNS outflow of GHRH [64, 287– 290]; (ii) hyposomatotropism in aging, wherein GHRH release may be diminished but is not absent [271, 29…”
BackgroundSelf-citation
Metadata
- Authors
- Bowers, C. Y., Granda, R., Mohan, S., Kuipers, J., Baylink, D., & Veldhuis, J. D.
- Affiliations
- Tulane University (US)
- Tulane University Health Sciences Center (C.Y.B., R.G.), New Orleans, Louisiana 70112
- Loma Linda University (US)
- Mayo Clinic (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-05-01
- Volume
- 89
- Issue
- 5
- Pages
- 2290-2300
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2016761387
- Semantic Scholar
- 250c06bc065bfefd59501d8ccba79ad312437c92
- Cited by
- 57
- References
- 115
- Citations by year
- 2025: 1 · 2023: 1 · 2021: 1 · 2019: 1 · 2017: 1 · 2015: 2 · 2014: 2 · 2013: 2 · 2012: 5
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG-19695, R01-AG14799, R01AG014799)
- National Center for Research Resources (RR-00585, M01-RR-05096, M01RR000585, M01RR005096)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- pulsatile growth hormone secretion, GHRP-2, growth hormone-releasing hormone, growth hormone, insulin-like growth factor I, IGF binding protein-3, IGF binding protein-5, aging, sex differences, continuous subcutaneous infusion, peptide synergy, older adults, growth hormone therapy, IGF-I bioactivity, IGF-I/IGFBP-3 ratio
- MeSH terms
- Aged, Drug Administration Schedule, Female, Humans, Infusion Pumps, Injections, Intravenous, Injections, Subcutaneous, Insulin-Like Growth Factor I, Male, Middle Aged, Oligopeptides, Osmolar Concentration, Pulsatile Flow, Reference Values, Cohort Studies, Insulin-Like Growth Factor Binding Protein 3, Insulin-Like Growth Factor Binding Protein 5, Human Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women. https://app.cochat.ai/papers/10.1210/jc.2003-031799
- The paper
- Bowers, C. Y., Granda, R., Mohan, S., Kuipers, J., Baylink, D., & Veldhuis, J. D. (2004). Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2003-031799
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.